Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 May;3(3):290–294. doi: 10.1128/cdli.3.3.290-294.1996

Detection of candidal antigens in autoimmune polyglandular syndrome type I.

P Peterson 1, J Perheentupa 1, K J Krohn 1
PMCID: PMC170334  PMID: 8705671

Abstract

Autoimmune polyglandular syndrome type I (APS I) is associated with chronic mucocutaneous candidiasis. To characterize the antibody responses in this subgroup of Candida albicans infections, we screened a candidal cDNA expression library with patient sera and found four cDNA clones encoding the immunopositive proteins enolase, heat shock protein 90, pyruvate kinase, and alcohol dehydrogenase. The reactivity to these antigens was studied further by immunoprecipitation assays with in vitro-transcribed and -translated proteins. Analysis of sera from 44 APS I patients showed that the highest antibody reactivity was found with enolase (80% of patients reactive), but significant serological responses were also found with heat shock protein 90 (67%), pyruvate kinase (62.5%), and alcohol dehydrogenase (64%). Overall, 95.5% of patients had detectable antibodies to at least one of these proteins. The cDNAs of enolase and heat shock protein 90 were also expressed in Escherichia coli and studied by immunoblotting. Again, 84% of sera reacted with enolase, whereas 44% of sera reacted with heat shock protein 90. A good correlation between the two methods was found for both enolase (r = 0.86; n = 58; P < 0.001) and heat shock protein 90 (r = 0.71; n = 56; P < 0.001). Our results indicate that the four abundant candidal proteins are the major antigens and can be used as accurate markers of candidiasis in APS I patients. The immunoprecipitation assay described here is particularly useful for the rapid analysis of a large number of samples.

Full Text

The Full Text of this article is available as a PDF (288.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen J., Björses P., Sandkuijl L., Perheentupa J., Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 1994 Sep;8(1):83–87. doi: 10.1038/ng0994-83. [DOI] [PubMed] [Google Scholar]
  2. Ahonen P., Myllärniemi S., Sipilä I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990 Jun 28;322(26):1829–1836. doi: 10.1056/NEJM199006283222601. [DOI] [PubMed] [Google Scholar]
  3. Arulanantham K., Dwyer J. M., Genel M. Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. N Engl J Med. 1979 Jan 25;300(4):164–168. doi: 10.1056/NEJM197901253000403. [DOI] [PubMed] [Google Scholar]
  4. Franklyn K. M., Warmington J. R., Ott A. K., Ashman R. B. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol Cell Biol. 1990 Jun;68(Pt 3):173–178. doi: 10.1038/icb.1990.24. [DOI] [PubMed] [Google Scholar]
  5. Germain M., Gourdeau M., Hébert J. Case report: familial chronic mucocutaneous candidiasis complicated by deep candida infection. Am J Med Sci. 1994 Apr;307(4):282–283. doi: 10.1097/00000441-199404000-00008. [DOI] [PubMed] [Google Scholar]
  6. Grubin C. E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W. A., Li L., Karlsen A. E., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994 Apr;37(4):344–350. doi: 10.1007/BF00408469. [DOI] [PubMed] [Google Scholar]
  7. Ishiguro A., Homma M., Torii S., Tanaka K. Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect Immun. 1992 Apr;60(4):1550–1557. doi: 10.1128/iai.60.4.1550-1557.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448–456. doi: 10.1007/BF01964059. [DOI] [PubMed] [Google Scholar]
  9. Krohn K., Uibo R., Aavik E., Peterson P., Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet. 1992 Mar 28;339(8796):770–773. doi: 10.1016/0140-6736(92)91894-e. [DOI] [PubMed] [Google Scholar]
  10. Matthews R. C., Burnie J. P., Howat D., Rowland T., Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology. 1991 Sep;74(1):20–24. [PMC free article] [PubMed] [Google Scholar]
  11. Matthews R. C., Burnie J. P., Tabaqchali S. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol. 1987 Feb;25(2):230–237. doi: 10.1128/jcm.25.2.230-237.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Matthews R., Burnie J. Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of Candida albicans. FEMS Microbiol Lett. 1989 Jul 1;51(1):25–30. doi: 10.1016/0378-1097(89)90071-2. [DOI] [PubMed] [Google Scholar]
  13. Matthews R., Burnie J., Smith D., Clark I., Midgley J., Conolly M., Gazzard B. Candida and AIDS: evidence for protective antibody. Lancet. 1988 Jul 30;2(8605):263–266. doi: 10.1016/s0140-6736(88)92547-0. [DOI] [PubMed] [Google Scholar]
  14. Matthews R., Burnie J. The role of hsp90 in fungal infection. Immunol Today. 1992 Sep;13(9):345–348. doi: 10.1016/0167-5699(92)90169-8. [DOI] [PubMed] [Google Scholar]
  15. Mitsutake K., Kohno S., Miyazaki T., Miyazaki H., Maesaki S., Koga H. Detection of Candida enolase antibody in patients with candidiasis. J Clin Lab Anal. 1994;8(4):207–210. doi: 10.1002/jcla.1860080405. [DOI] [PubMed] [Google Scholar]
  16. Qian Q., Jutila M. A., Van Rooijen N., Cutler J. E. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994 May 15;152(10):5000–5008. [PubMed] [Google Scholar]
  17. Shen H. D., Choo K. B., Lee H. H., Hsieh J. C., Lin W. L., Lee W. R., Han S. H. The 40-kilodalton allergen of Candida albicans is an alcohol dehydrogenase: molecular cloning and immunological analysis using monoclonal antibodies. Clin Exp Allergy. 1991 Nov;21(6):675–681. doi: 10.1111/j.1365-2222.1991.tb03195.x. [DOI] [PubMed] [Google Scholar]
  18. Strebel K., Beck E., Strohmaier K., Schaller H. Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol. 1986 Mar;57(3):983–991. doi: 10.1128/jvi.57.3.983-991.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sundstrom P., Aliaga G. R. Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J Bacteriol. 1992 Nov;174(21):6789–6799. doi: 10.1128/jb.174.21.6789-6799.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Swoboda R. K., Bertram G., Hollander H., Greenspan D., Greenspan J. S., Gow N. A., Gooday G. W., Brown A. J. Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis. Infect Immun. 1993 Oct;61(10):4263–4271. doi: 10.1128/iai.61.10.4263-4271.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thompson H. L., Wilton J. M. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions. Clin Exp Immunol. 1992 Feb;87(2):316–321. doi: 10.1111/j.1365-2249.1992.tb02994.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Uibo R., Aavik E., Peterson P., Perheentupa J., Aranko S., Pelkonen R., Krohn K. J. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab. 1994 Feb;78(2):323–328. doi: 10.1210/jcem.78.2.8106620. [DOI] [PubMed] [Google Scholar]
  23. Walsh T. J., Hathorn J. W., Sobel J. D., Merz W. G., Sanchez V., Maret S. M., Buckley H. R., Pfaller M. A., Schaufele R., Sliva C. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med. 1991 Apr 11;324(15):1026–1031. doi: 10.1056/NEJM199104113241504. [DOI] [PubMed] [Google Scholar]
  24. Winqvist O., Gustafsson J., Rorsman F., Karlsson F. A., Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 1993 Nov;92(5):2377–2385. doi: 10.1172/JCI116843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Winter W. E., Obata M., Maclaren N. K. Clinical and molecular aspects of autoimmune endocrine disease. Concepts Immunopathol. 1992;8:189–221. [PubMed] [Google Scholar]
  26. van Deventer A. J., van Vliet H. J., Hop W. C., Goessens W. H. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol. 1994 Jan;32(1):17–23. doi: 10.1128/jcm.32.1.17-23.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES